Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Emma Walmsley

GSK reports promising early results in ovarian and womb cancer drug trial

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug

The Guardian - UK

Emma Walmsley’s pay rose almost 50% to £15.6m in final year as GSK boss

Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise

The Guardian - UK

GSK, take two: the bullish tone at the top is finally more convincing

New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

GSK posts higher profits but indicates sales growth to slow in 2026

It came amid the first set of results by new chief executive Luke Miels, who took over from Emma Walmsley at the turn of the year.

Evening Standard

The UK’s pharma deal was vital – but the GSK boss is right about US dominance

It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pact

The Guardian - UK

US is the best place for drug companies to invest, says boss of London-based GSK

Emma Walmsley’s praise for US pharmaceutical market piles pressure on UK government

The Guardian - UK

UK must reform drug pricing to become life sciences superpower, says GSK boss

Shares jump on higher profits as Emma Walmsley is ‘hopeful’ standoff with NHS can be resolved

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

GSK boosted by cancer and HIV drugs as Emma Walmsley bows out

Shares in the company rose on Wednesday morning as a result, lifting to their highest level for more than a year.

Evening Standard

GSK chief doesn't buy that the CEO role has become unsustainable

The co-CEO model may work with the right “cocktail” combination, but CEOs must be prepared to give the position “everything you possibly have,” she said.

Fortune

Are trees getting taller? Plus teenage smoking and why females live longer

These are the most groundbreaking stories from the new frontier of science and technology right now

Evening Standard

Emma Walmsley steadied GSK – but doubts linger over growth targets

The outgoing chief executive reshaped the drugmaker, yet scepticism persists over promised revenues

The Guardian - UK

FTSE 100 held back by weak oil after bright start

The FTSE 100 index closed up 0.2% at 9,299.84.

Evening Standard

Emma Walmsley To Step Down As GSK CEO After Nine Years, Luke Miels To Lead Starting January 2026

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026.

Benzinga

CEO of drugmaker GSK to step down by year's end

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Emma Walmsley steps down as CEO of GSK as pharmaceutical industry faces upheaval

The drug and vaccine maker is a £60bn firm – one of the biggest in the UK

International Business Times

GSK Switches CEO As Trump Tariffs Test Pharma

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief commercial officer in January, as the company navigates US tariffs on the sector.

Evening Standard

GSK’s boss Emma Walmsley to step down after eight-year tenure

Dame Emma was the first woman to run a major pharmaceutical company when she became chief executive in 2017.

The Guardian - UK

GSK’s Emma Walmsley to step down as chief executive after eight years

Chief commercial officer Luke Miels to take over as CEO at Britain’s second-biggest drugmaker

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

FTSE 100 Live 29 September: Index nears record, GSK shares rise on CEO change

GSK chief executive Emma Walmsley is to step down after more than eight years running the pharmaceuticals giant.

Fortune

Queens of influence: Meet the women shaping Europe's future

In its 28th year, the annual MPW list recognizes 100 women leading major global companies. This year, 21 listees are at the helm of European companies.

Evening Standard

Drugs giant GSK ‘well positioned’ to absorb potential US tariffs

It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality medicines.

Fortune

GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt

Emma Walmsley says her "180" would probably tell her to say "thank yous" and "well dones."

Fortune

Power Players: Meet the women reshaping 10 key European industries

This year, Fortune curated a list of female leaders at the helm of European companies across the continent’s biggest industries.

The Guardian - UK

British pharma company GSK pauses diversity work citing Trump orders

London-based FTSE 100 firm reviewing its policies, saying it is obliged to comply because US is its No 1 market

Fortune

GSK could double CEO Emma Walmsley's pay to $27 million

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.